"Regulators last week ordered the Jilin-based Changsheng Biotechnology to stop production of a rabies vaccine, after investigators found fabricated production and inspection records during an inspection...Changsheng said in a stock market filing later in the week that authorities were punishing the company over a “substandard” DPT vaccine for diphtheria, pertussis, and tetanus…Chinese state media reported that 250,000 doses of the DPT vaccine in question had been sold to the province of Shandong"